The SERENA-6 trial shows a 54% reduced risk of death with camizestrant, with a median PFS of 16.6 months versus 9.2 months ...

Genetic risk models and variant classification tools are refining breast cancer risk assessment by identifying high-risk ...

1. Lou A, Elnenaei M, Liu E, et al. Evaluation of a novel albumin platelet product (APP) fibrosis index and three ...

A late-breaking presentation at the American Society of Hematology (ASH) 2025 meeting revealed promising phase 3 findings for ...

A preoperative low-energy, high-protein diet led to significant weight loss and improved postoperative symptoms in colorectal ...

Innovative smart pill bottles significantly enhance adherence to oral adjuvant endocrine therapy in early-stage breast cancer ...

AMCP Nexus 2025 explored innovative health care policies, oncology advancements, and the impact of new regulations on patient ...

For adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL), the steepest barriers to high-quality care ...

Experts at a roundtable in Boston, Massachusetts, on November 3, 2025, discussed improving early Alzheimer disease diagnosis, addressing workforce and equity gaps, and expanding access to new ...

The proposed legislation seeks to extend ACA subsidies, extend open enrollment, and lower out-of-pocket caps to prevent ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

With neither health care plan receiving the required votes from the Senate today, there are only 3 weeks for Congress to come up with a solution to the ACA premiums expiring in the new year. Should no ...